Education
Harvard Business School
MBA, Business 2001-01-01 - 2002-06-01University of Cambridge
MEng, Chemical Engineering 1993-01-01 - 1994-01-01University of Cambridge
MA, Natural Sciences/Chemical Engineering 1990-01-01 - 1993-01-01Hutchesons' Grammar School, Glasgow, Scotland
, 1985-01-01 - 1989-01-01Work Experience
Merck KGaA, Darmstadt, Germany
2018-01-01 - 2019-01-01
Merck KGaA, Darmstadt, Germany
Bayer
2015-01-01 - 2018-01-01
Bayer
Bristol Myers Squibb
2012-01-01 - 2015-01-01
Bristol Myers Squibb
Novartis Oncology
2010-01-01 - 2012-01-01
Novartis Oncology
Novartis
2008-01-01 - 2010-01-01
Novartis
Novartis Oncology
2007-01-01 - 2008-01-01
Novartis Oncology
Novartis
2005-01-01 - 2007-01-01
Novartis
Analysis Group
2002-01-01 - 2005-01-01
Analysis Group
Arthur D. Little
1994-01-01 - 2000-01-01
Arthur D. Little
Skills
Summary
I'm a biopharma leader with deep international experience in oncology-hematology, and a proven record in driving global launches, managing strategic transactions & alliances, and leading/coaching teams to superior performance. I combine strategic thinking skills with strong operational P&L experience in marketing & sales. I enjoy working at the interface of research, development and commercialization to promote innovation, speed and better outcomes for patients and their providers. My experience spans the product life cycle from pre-PoC planning through commercial launch to managing maturity (e.g. LoE, generics, biosimilars).